{"product_id":"biolegend-123127","title":"Biolegend, 123127, PerCP\/Cyanine5.5 anti-mouse F4\/80 Antibody, 25μg","description":"\u003cp\u003eF4\/80, also known as EMR1 or Ly71, is a 160 kD glycoprotein of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4\/80 has been widely used as a murine macrophage marker. It is expressed on a majority of tissue macrophages, including macrophages in the lung, gut, peritoneal cavity, thymus, and red pulp of the spleen, Kupffer cells, Langerhans cells, microglia, and certain dendritic cells. It is not expressed on macrophages located in the T cell areas of the spleen, lymph node, or Peyer's patch. The biological ligand of F4\/80 has not been identified, but it has been reported that F4\/80 is required for the induction of CD8 + T cells-mediated peripheral tolerance.\u003cbr\u003e\n25μg\u003cbr\u003e\nVerified Reactivity: Mouse\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Rat\u003cbr\u003e\nImmunogen: Murine macrophages\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography, and conjugated with PerCP\/Cyanine5.5 under optimal conditions.\u003cbr\u003e\nConcentration: 0.2 mg\/ml\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 1.0 µg per 106 cells in 100 µl. It is recommended that the reagent be titrated for optimal performance for each application.* PerCP\/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.\u003cbr\u003e\nExcitation Laser: Blue Laser (488 nm)\u003cbr\u003e\nApplication Notes: Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC) Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC) Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC) Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC) Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed Watson NB, et al. 2015. J Immunol. 194:2796. PubMed Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed\u003cbr\u003e\nProduct Citations: Serra-Hassoun M, et al. 2014. J Immunol. 193:1504. PubMed Lin D, et al. 2016. Cancer Res . 76: 3179 - 3188. PubMed Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed Tong CF, et al. 2018. Am J Physiol Cell Physiol. 315:C409. PubMed Jaitin DA, et al. 2020. Cell. 178(3):686-698.e14.. PubMed Boroumand P, et al. 2022. Elife. 11:. PubMed Shi H, et al. 2022. Nutrients. 14:. PubMed Wu Z, et al. 2023. EMBO Rep. 24:e56524. PubMed Li M, et al. 2023. BMC Cancer. 23:497. PubMed Bernasconi R, et al. 2021. EMBO Mol Med. :e14392. PubMed Fu A, et al. 2022. Cell. 185:1356. PubMed Van Deren DA, et al. 2022. Development. 149: . PubMed Lee R, et al. 2022. Cancer Discov. 12:1702. PubMed Serra M, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:609. PubMed Mansouri S, et al. 2022. J Immunol. 209:2114. PubMed He Y, et al. 2022. Front Immunol. 13:986202. PubMed Kawasaki T, et al. 2022. Cell Rep. 41:111828. PubMed Parida PK, et al. 2022. Cell Metab. 34:90. PubMed Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed Correa S, et al. 2020. ACS Nano. 14:2224. PubMed Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed Kaku H, et al. 2014. J Immunol. 193:5904. PubMed Li Q, et al. 2019. Neuron. 101:207. PubMed Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed Balog S, et al. 2020. Hepatology. 71:291. PubMed Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed Tyagi AM et al. 2018. Immunity. 49(6):1116-1131 . PubMed Deslyper G, et al. 2021. Parasitology. 148:539. PubMed Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed Thompson PJ et al. 2019. Cell metabolism. 29(5):1045-1060 . PubMed Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed Jones N, et al. 2021. Nat Commun. 12:1209. PubMed Mul Fedele ML, et al. 2020. Front Cell Infect Microbiol. 10:100. PubMed Brykczynska U, et al. 2020. Cell Reports. 30(5):1627-1643.e7.. PubMed Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed Saint Fleur–Lominy S, et al. 2018. Cell Rep. 24:3045. PubMed Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed Zhang P, et al. 2022. BMC Med. 20:435. PubMed Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed Zellweger R, et al. 2010. Cell Host Microbe. 18:128. PubMed Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed Si Y, et al. 2018. J Control Release. 282:120. PubMed Pitsch J, et al. 2021. Ann Neurol. 89:666. PubMed McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed Garg M, et al. 2021. Cell Reports. 34(6):108736. PubMed Chen Z, et al. 2015. Am J Physiol Endocrinol Metab. 308:460. PubMed Boehm DT, et al. 2018. Infect Immun. 86:. PubMed Jiang W, et al. 2021. J Cell Physiol. 236:7711. PubMed Brandi P, et al. 2022. Cell Rep. 38:110184. PubMed Momin N, et al. 2022. Nat Commun. 13:109. PubMed Kren N, et al. 2020. Sci Rep. 10:7390. PubMed Vogel AB, et al. 2021. Nature. 592:283. PubMed Macdougall CE et al. 2018. Cell metabolism. 27(3):588-601 . PubMed Longenecker JZ, et al. 2021. Mol Metab. 54:101343. PubMed Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed Huang D, et al. 2020. Nat Commun. 4.520833333. PubMed Lim S, et al. 2016. PLoS One. 11: 0155689. PubMed Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed Song P, et al. 2018. Int J Mol Med. 41:935. PubMed Bachy S, et al. 2022. iScience. 25:103758. PubMed RY H, et al. 2016. Oncoimmunology. 6:e1249561. PubMed Xu P, et al. 2020. Cancer Immunol Res. 8:1193. PubMed Duan H et al. 2018. Immunity. 49(2):301-311 . PubMed Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed Traboulsi H, et al. 2015. Antimicrob Agents Chemother. 59: 6317. PubMed Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed Chen X, et al. 2021. Immunity. 54(2):324-339.e8. PubMed Meunier I, et al. 2015. PLoS One. 10: 0138055. PubMed Watson N, et al. 2015. J Immunol. 194:2796. PubMed Buerfent BC, et al. 2019. GMS Infect Dis. 7:Doc04. PubMed Wu M, et al. 2020. Mucosal Immunol. 13:47. PubMed Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed Howard ZM, et al. 2021. Am J Pathol. 191:730. PubMed Zheng Y, et al. 2022. J Immunol. 208:501. PubMed Zhang X, et al. 2020. Arterioscler Thromb Vasc Biol. 40:597. PubMed Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed Chen X, et al. 2022. STAR Protoc. 3:101180. PubMed Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed Kim SI, et al. 2020. Molecular Cancer Therapeutics. 20(1):173-182. PubMed Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed Hwang BJ, et al. 2022. J Immunother Cancer. 10:. PubMed Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed Rodrigues TS, et al. 2020. J Leukoc Biol. 108:1225. PubMed Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed Zhong J, et al. 2021. Commun Biol. 4:865. PubMed Koda S, et al. 2021. Front Immunol. 12:754208. PubMed\u003cbr\u003e\nRRID: AB_893496 (BioLegend Cat. No. 123127) AB_893484 (BioLegend Cat. No. 123128)\u003cbr\u003e\nStructure: EGF-TM7 family member, 160 kD glycoprotein\u003cbr\u003e\nDistribution: Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kupffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells\u003cbr\u003e\nFunction: Induction of immunological tolerance\u003cbr\u003e\nCell Type: Dendritic cells, Langerhans cells, Macrophages, Tregs\u003cbr\u003e\nBiology Area: Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience\u003cbr\u003e\nAntigen References: 1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805. 2. Hume DA, et al. 1983. J. Exp. Med. 158:1522. 3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801. 4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486. 5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.\u003cbr\u003e\nGene ID: 13733\u003cbr\u003e\nUniProt: View information about F4\/80 on UniProt.org\u003cbr\u003e\nClone: BM8\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nOther Names: EMR1, Ly71\u003cbr\u003e\nIsotype: Rat IgG2a, κ\u003cbr\u003e\nQ: How stable is PerCP\/Cyanine5.5 tandem as compared to PerCP alone?\u003cbr\u003e\nA: PerCP\/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46862913765545,"sku":"123127","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/es\/products\/biolegend-123127","provider":"Iright","version":"1.0","type":"link"}